Relevant bibliographies by topics / Diabetes – Treatment

Academic literature on the topic 'Diabetes – Treatment'

Author: Grafiati
Published: 4 June 2021
Last updated: 1 August 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Diabetes – Treatment.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Diabetes – Treatment"

1

Mammen, Dr Sheena A. "Knowledge of Diabetes, its Treatment and Complications in Diabetic Patients." Journal of Medical Science And clinical Research 05, no. 05 (May 12, 2017): 21838–40. http://dx.doi.org/10.18535/jmscr/v5i5.99.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Khalid Iqbal, Rana. "Type 2 Diabetes and its Treatment." Diabetes & Obesity International Journal 4, no. 3 (2019): 1–3. http://dx.doi.org/10.23880/doij-16000208.

Full text
Abstract:
Type 2 diabetes is chronic disease that is spreading all over the world. In type 2 diabetes mainly there is less insulin production. It can be diet-induced and may also be associated with obesity. The body weight of a person increases due to more energy taken by the food, also the physical activity with less workout may lead to abdominal adiposity and finally the insulin resistance. Insulin resistance leads to the development of type 2 diabetes. The ratio of diabetic patients is increasing day by day. 90% of the total diabetic patients have type 2 diabetes. The risk of developing type 2diabetes is increasing according to an estimation of the American born in 2000 or later one of the three and some 50% members are expected to have type 2 diabetes.
APA, Harvard, Vancouver, ISO, and other styles
3

Bloomgarden, Z. T. "Diabetes Treatment." Diabetes Care 32, no. 3 (February 26, 2009): e25-e30. http://dx.doi.org/10.2337/dc09-zb03.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

&NA;. "Diabetes Treatment Breakthroughs." American Journal of Nursing 98, no. 10 (October 1998): 56. http://dx.doi.org/10.1097/00000446-199810000-00040.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Kuehn, Bridget M. "Diabetes Treatment Doubles." JAMA 305, no. 8 (February 23, 2011): 770. http://dx.doi.org/10.1001/jama.2011.182.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Luo, Juhua, Beth Virnig, Michael Hendryx, Sijin Wen, Rowan Chelebowski, Chu Chen, Tomas Rohan, et al. "Diabetes, diabetes treatment and breast cancer prognosis." Breast Cancer Research and Treatment 148, no. 1 (September 27, 2014): 153–62. http://dx.doi.org/10.1007/s10549-014-3146-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Sung, Hsing-Wen, Kiran Sonaje, and Si-Shen Feng. "Nanomedicine for diabetes treatment." Nanomedicine 6, no. 8 (October 2011): 1297–300. http://dx.doi.org/10.2217/nnm.11.124.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Fowler, M. J. "Diabetes Treatment: Oral Agents." Clinical Diabetes 28, no. 3 (June 1, 2010): 132–36. http://dx.doi.org/10.2337/diaclin.28.3.132.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Deepika, V., L. Harsha, and Aishwarya Ravishankar. "Treatment of Diabetes Insipidus." Research Journal of Pharmacy and Technology 8, no. 6 (2015): 767. http://dx.doi.org/10.5958/0974-360x.2015.00123.7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Oba, Kenzo. "Treatment guide for diabetes." Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 48, no. 6 (2011): 640–43. http://dx.doi.org/10.3143/geriatrics.48.640.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Diabetes – Treatment"

1

Pickavance, Lucy Cecilia. "Thiazolidinedione treatment in models of insulin resistance." Thesis, University of Liverpool, 2001. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.367553.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Ryysy, Leena. "Insulin treatment in type 2 diabetes." Helsinki : University of Helsinki, 2001. http://ethesis.helsinki.fi/julkaisut/laa/kliin/vk/ryysy/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Vincent, Dawn A. "Acceptance of complementary and alternative medicine among pediatric patients with diabetes." Virtual Press, 2007. http://liblink.bsu.edu/uhtbin/catkey/1366504.

Full text
Abstract:
The purpose of this research study was to determine the acceptability of complementary and alternative medicine use in a pediatric population with diabetes. Subjects included 76 patients who attend or have previously attended a diabetes clinic at Riley Hospital for Children in Indianapolis, Indiana.Once patient and parent approval had been granted, the researcher conducted a telephone interview to gather information. Using SPSS statistical software, frequencies and Chi-squared analysis were performed on the data collected. It was revealed that although subjects had a wide variety of concerns with the use of CAM and were unsure about whether it "could heal diabetes or other health problems," a majority were willing to try CAM. Results also indicated that willingness to try CAM was not affected by the age of the child, the type of diabetes present, use of insulin or special diet, or current use of a vitamin or supplement.
Department of Family and Consumer Sciences
APA, Harvard, Vancouver, ISO, and other styles
4

Dickason, Beverley Janine. "Optimisation of pharmacological management of diabetes mellitus in a primary health care setting." Thesis, Nelson Mandela Metropolitan University, 2007. http://hdl.handle.net/10948/846.

Full text
Abstract:
Levels of diabetic care in primary health care settings in South Africa have been found to be sub-optimal. Knowledge deficits and inadequate practices have been implicated in the poor quality of local diabetes care. Type 2 diabetes and hypertension are commonly associated chronic conditions hence to optimise diabetic care, tight control of blood pressure is essential. Although guidelines for the overall management of diabetes in a primary health care setting have been published (Working Group of the National Diabetes Advisory Board, 1997; Society for Endocrinology, Metabolism and Diabetes of South Africa, 2002a), adherence to these guidelines has not yet been optimised in the primary health care setting. The objectives of the study were: to design and implement an educational intervention aimed at nursing staff, based on the South African guidelines for type 2 diabetes and hypertension, at a public sector primary health care clinic; to determine the impact of the educational intervention on the level of knowledge and attitudes of the nursing staff, and on the level of diabetic and blood pressure control achieved in the patient population, and to determine the impact of the educational intervention on pharmacological management of patients. A questionnaire was used to quantitatively assess the nursing staffs’ knowledge of the management of type 2 diabetes and hypertension at a primary health care level. A qualitative evaluation of the nursing staff attitudes was obtained using focus group interviews. The educational intervention, in the form of lectures and based on national diabetes and hypertension guidelines (Working Group of the National Diabetes Advisory Board, 1997; Society for Endocrinology, Metabolism and Diabetes of South Africa, 2002a; Milne et al., 2003), was then implemented and directed at the nursing staff at a primary health care clinic. A post-intervention evaluation was performed after four months by repeating the questionnaire and focus group interviews. Comparisons between the pre- and post-intervention questionnaire and focus group interviews evaluated the impact of the educational intervention on the knowledge and attitudes of nursing staff towards the management of type 2 diabetes. Pre- and post-intervention patient data was collected from patient medical files and compared to determine if the management of diabetes and hypertension improved in the patient population after the implementation of the educational intervention. The patient population consisted of 103 patients. The educational intervention resulted in an extremely significant improvement in the level of knowledge of the nursing staff [93 correct responses (28.3 percent; n = 329 (pre-intervention)) vs 223 correct responses (67.8 percent; n = 329 (post-intervention)); p < 0.0001, Fisher’s Exact test]. The educational intervention resulted in improved attitudes of nursing staff towards the management of diabetes. Ideal random blood glucose concentrations improved significantly [16 percent; n = 100 (pre-intervention) vs 22 percent; n = 100 (post-intervention); p = 0.0003; Student t test]. The number of patients with a compromised HbA1c level (> 8 percent) decreased by 2 [51; 49.5 percent, n = 103 (pre-intervention) vs 49, 47.5 percent, n = 103 (post-intervention)] which was not a significant improvement. Ideal blood pressure control improved by one from 38 patients [36.9 percent; n = 103 (pre-intervention)] to 39 patients [37.9 percent; n = 103 (post-intervention)] which was not significant. Optimal change of pharmacological management following the referral of an uncontrolled diabetic patient was only noted for 18 patients (20.2 percent, n = 89) referred in the post-intervention phase. Clinical inertia was identified as a major limitation to the optimisation of diabetes care. Implementation of an educational intervention based on the South African diabetes and hypertension guidelines at a public sector primary health care clinic was successful in improving the knowledge levels and attitudes of nursing staff
APA, Harvard, Vancouver, ISO, and other styles
5

Wolffenbuttel, Bruce Herbert Ralph. "Type 2 diabetes mellitus pathology and treatment /." Maastricht : Maastricht : Datawyse ; University Library, Maastricht University [Host], 1991. http://arno.unimaas.nl/show.cgi?fid=5673.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Tong, King-hung Daniel, and 唐琼雄. "Surgical treatment for type II diabetes mellitus." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2013. http://hdl.handle.net/10722/193510.

Full text
Abstract:
Introduction: Historically, type 2 diabetes (T2DM) has been regarded as a progressive and degenerative disease and only minority of patients can have disease remission with conventional treatment. It was noticed that gastrointestinal surgery could induce complete remission of T2DM in most of morbidly obese patients. Compared to the West, the development of bariatric and metabolic surgery is slow in Hong Kong. It is unknown whether the knowledge and attitudes of medical doctors and patients towards surgical treatment for T2DM have impacts on the development in this field. The novel procedure sleeve gastrectomy (SG) had been shown to be effective in inducing T2DM remission in obese human. Duodenal jejunal bypass (DJB) and ileal transposition (IT) were reported to be effective for ameliorating T2DM in non-obese diabetic animal model. The anti-diabetic potency of DJB and IT is unknown in comparing to SG particularly in non-obese subjects. Currently, SG is the main procedure for morbidly obese patients with or without T2DM in the authors’ institution. Aims: The aims of the present thesis were to investigate the knowledge and attitudes of medical doctors and patients toward using surgery as a treatment for T2DM, to compare the anti-diabetic effect of SG, DJB and IT in non-obese T2DM animal model, and lastly, to review of outcomes of morbidly obese patients who underwent SG in authors’ institution. Methods: Survey was conducted using questionnaire for interview of both doctors and patients to investigate their knowledge and attitudes toward surgical treatment of T2DM. The anti-diabetic effects of novel surgical procedures SG, DJB and IT were compared using non-obese T2DM animal model (Goto Kakizaki rats). The outcomes were evaluation by measuring fasting glucose and glycosylated haemoglobin (HbA1c) levels. Other parameters including alteration in gut hormones and lipid profile were also analyzed. The outcomes of morbidly obese patients who underwent laparoscopic SG in last 5 years in the authors’ institution were retrospectively reviewed. Results: The knowledge of bariatric and metabolic surgery was inadequate both in medical doctors and patients. The attitude and pattern of referral from medical doctors depends on the amount of knowledge. Patients’ attitudes were positive and they accept surgery as a treatment option for T2DM as long as they were provided with adequate information. This implies that tremendous educational works are required both for medical doctors and patients for the development of bariatric and metabolic surgery in Hong Kong. All 3 procedures (SG, DJB and IT) significantly improved glucose homeostasis and the effect was more potent and durable in DJB and IT than SG. The improved glucose homeostasis in IT was resulted from increased GLP-1 and PYY secretion (hindgut theory). In DJB, GIP, GLP-1 and PYY were raised and the anti-diabetic effect could be explained both by the foregut and hindgut theories. SG reduced the diet triglyceride absorption. DJB reduced cholesterol absorption whereas IT reduced cholesterol but increase triglyceride absorption. The outcomes of SG for T2DM for morbidly obese patients were promising. More than 90% patients had T2DM ameliorated and 70% had complete remission. SG can effectively control the body weight of morbidly obese patients. Conclusion: Education, both to doctors and patients, was crucial to overcome the potential obstacles for the development of this newly specialty. The anti-diabetic effects of DJB and IT were more potent than SG in non-obese diabetic animal model. The lipid absorption varied in different surgical procedures. Application of these procedures in non-obese T2DM patients warrants individual consideration and further investigation. SG in the authors’ institution was effective to induce T2DM remission in morbidly obese patients.
published_or_final_version
Surgery
Doctoral
Doctor of Philosophy
APA, Harvard, Vancouver, ISO, and other styles
7

Debbri, Hawa Abdulgader. "Plant extracts as treatment for diabetes mellitus." Thesis, University of Glasgow, 1996. http://theses.gla.ac.uk/2113/.

Full text
Abstract:
The herbal extract of Artemisia has been regarded to be anti-hyperglycaemic since olden times and is commonly used by diabetics in Libya. The present work was designed to evaluate, test and determine which fraction or component of the herb had the hypoglycaemic effects in normal and streptozotocin-induced diabetic rats. The plant extract was administered to the animals in their drinking water and body weight, food and fluid intake and urine volume were all monitored daily. Food and fluid intake and body weight gain in normal rats were not altered by treatment with the plant extract but there was a rise in the urine glucose in the first six rats but rats 7, 8 and 9 were not affected by treatment with plant. Urine volume was increased in all rats suggesting Artemisia judaica is a mild diuretic. The streptozotocin-induced diabetic rat model, used in this study, was associated with the characteristic diabetic symptoms of hyperphagia, hyperglycaemia, polydipsia, weight loss and urinary glucose excretion. When a crude aqueous extract of Artemisia was given in their drinking water, it had little effect on these symptoms after 10 days of treatment. Urine glucose was reduced in the last two days and ketones in the urine were abolished by this treatment. Diabetes mellitus is known to affect many and varied parameters in rat liver. Insulin, biguanides and sulphonylureas are known antidiabetic diabetic treatments. Artemisia judaica extract was tested for its effect on hepatic steroid metabolism and glycogen phosphorylase a activity in comparison with the above drugs. Clearly Artemisia does act as an insulin-mimetic in these assays by reversing all the effects produced by the administration of streptozotocin. In particular the changes in the enzyme activities of cytochrome P-450 (2E1, 2B and 2C) on androst-4-ene-3, 17-dione metabolism are all reversed by the administration of Artemisia extract to diabetic rats.
APA, Harvard, Vancouver, ISO, and other styles
8

Pearson, Ewan Robert. "The physiology and treatment of monogenic diabetes." Thesis, University of Exeter, 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.414848.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Pearson, E. R. "The physiology & treatment of monogenic diabetes." Thesis, Exeter and Plymouth Peninsula Medical School, 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.701066.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

WHITE, NANCY EDNA. "AN EMPIRICAL TEST OF A THEORETICAL MODEL TO EXPLAIN ADHERENCE TO A DIABETIC THERAPEUTIC REGIMEN." Diss., The University of Arizona, 1985. http://hdl.handle.net/10150/188059.

Full text
Abstract:
The purpose of this research was to investigate the impact of social support on adherence to a therapeutic regimen among obese Type II diabetic clinic patients. The aims of the study were to compare the effect of small reference group management with an educational advice program on the therapeutic outcomes of adherence and to test a theoretical model proposed to explain adherence to a diabetic regimen. The concepts of the model were derived from symbolic interactionist and role theory. Forty-one patients attending an outpatient diabetic clinic were randomly assigned to the two treatment programs and 32 patients completed the 6 month study. Subjects met for a total of 10 one-hour sessions which were held weekly the first month, biweekly the second month, and monthly the final 4 months. Demographic information, knowledge of diabetes, and measures of the model variables (social support, health locus of control, health perceptions, diabetic belief, regimen adherence), were collected at the start (t₁) and the termination of the study (t₁₀). Analysis of audiotapes recorded at t₂ and t₉ indicated that patient-initiated interactions were significantly longer in duration for the small reference group. The experimental group also demonstrated significantly lower blood glucose values at t₁₀, however, there was not a corresponding difference between groups in glycohemoglobin, urine glucose, or percent overweight. The total sample experienced a significant mean reduction in glycohemoglobin (-11.1%; p < .05) and an increase in social support and knowledge. Serial blood glucose and glycohemoglobin values indicated improvement in diabetic control was more marked when subjects met weekly or biweekly and stabilized or worsened when meetings were reduced. The staged recursive theoretical model was analyzed using multiple regression statistics. The empirical test of the model of t₁ indicated minimal support in terms of significant explained variance in 6 of the 8 dependent variables. In addition, some of the path coefficients indicated a possible interaction effect between resistance and locus of control. The t₁₀ model demonstrated cohesion among the first three stages of independent variables and greater explained variance, however, multicollinearity proved to be a significant problem when interpreting the path coefficients.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Diabetes – Treatment"

1

Kim, Yŏng-sŏl. Tangnyo chŏngbok: Tangnyopyŏng ŭro san cha wa chugŭn cha. Sŏul T'ŭkpyŏlsi: Puk aen Edyu, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Day, John L. The diabetes handbook: Insulin dependent diabetes. Wellingborough: Thorsons in collaboration with the British Diabetic Association, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Davidson, Mayer B. Diabetes mellitus: Diagnosis and treatment. 4th ed. Philadelphia: Saunders, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Day, John L. The diabetes handbook: Non-insulin dependent diabetes. Wellingborough: Thornsons in collaboration with the British Diabetic Association, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

D, Andreani, ed. Diabetic complications: Early diagnosis and treatment. Chichester [West Sussex]: Wiley, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

A, DeFronzo Ralph, ed. Current therapy of diabetes mellitus. St. Louis: Mosby, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

RD, Powers Margaret A., ed. Handbook of diabetes nutritional management. Rockville, Md: Aspen Publishers, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Lippincott Williams & Wilkins., ed. Diabetes mellitus: A guide to patient care. Philadelphia: Lippincott Williams & Wilkins, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Centers for Medicare & Medicaid Services (U.S.), ed. Diabetes booklet. [Baltimore, Md.]: Centers for Medicare & Medicaid Services, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Peters, M. D. Anne. Conquering Diabetes. New York: Penguin USA, Inc., 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Diabetes – Treatment"

1

Minaker, Kenneth L., and Linda A. Morrow. "Treatment of Diabetes." In Geriatric Medicine, 481–90. New York, NY: Springer New York, 1997. http://dx.doi.org/10.1007/978-1-4757-2705-0_32.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Du Port, François. "Treatment of Diabetes." In The Decade of Medicine or The Physician of the Rich and the Poor, 165–66. Berlin, Heidelberg: Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-73715-2_217.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Lansang, M. Cecilia, Richard David Leslie, Tahseen A. Chowdhury, and Keren Zhou. "Insulin treatment and pancreatic/islet cell transplantation." In Diabetes, 181–204. 2nd ed. Boca Raton: CRC Press, 2022. http://dx.doi.org/10.1201/9781003240341-15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

McMillan, Nadia, and Christopher H. Gibbons. "Treatment Induced Neuropathy of Diabetes." In Contemporary Diabetes, 157–63. Cham: Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-15613-7_9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Blackberry, Irene. "Diabetes." In Practical Strategies and Tools to Promote Treatment Engagement, 187–209. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-49206-3_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Rippe, James M. "Obesity and Diabetes." In Obesity Prevention and Treatment, 151–63. Boca Raton: CRC Press, 2021. http://dx.doi.org/10.1201/9781003099116-15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Dobmeyer, Anne C. "Diabetes." In Psychological treatment of medical patients in integrated primary care., 101–19. Washington: American Psychological Association, 2018. http://dx.doi.org/10.1037/0000051-008.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Giurini, John M. "Surgical Treatment of the Ulcerated Foot." In Contemporary Diabetes, 305–25. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-89869-8_19.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Ceja Solorio, Juan, and John M. Giurini. "Surgical Treatment of the Ulcerated Foot." In Contemporary Diabetes, 405–31. Cham: Springer International Publishing, 2024. http://dx.doi.org/10.1007/978-3-031-55715-6_23.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Dodson, P. M. "Dietary Aspects of Treatment." In Diabetes and Hypertension, 95–101. Berlin, Heidelberg: Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-73232-4_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Diabetes – Treatment"

1

Leshchenko, Sofiia, and Viktoriia Horina. "THIAZOLIDINE IN THE TREATMENT OF DIABETES." In THEORETICAL AND PRACTICAL ASPECTS OF MODERN SCIENTIFIC RESEARCH, Chair Anastasiya Marchenko and Liliva Bobro. European Scientific Platform, 2023. http://dx.doi.org/10.36074/logos-28.04.2023.78.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Chen, Feier. "Balancing treatment of COVID-19 with diabetes." In International Conference on Biomedical and Intelligent Systems (IC-BIS 2022), edited by Ahmed El-Hashash. SPIE, 2022. http://dx.doi.org/10.1117/12.2660059.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Ehtisham, Sarah. "5 An update on obesity and type 2 diabetes treatment." In The 6th ASPED-ISPAD Diabetes Academy. BMJ Publishing Group Ltd, 2023. http://dx.doi.org/10.1136/bmjpo-2023-asped.5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Otter, S., O. Scholz, A. Welters, J. Mrugala, H. Diran, T. Meissner, E. Mayatepek, D. Eberhard, and E. Lammert. "Peripherally Restricted DXO Derivates for the Treatment of Diabetes Mellitus." In Diabetes Kongress 2019 – 54. Jahrestagung der DDG. Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-1688191.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Jacob, S., R. Silver, J. Gumprecht, T. Vilsbøll, T. Hansen, J. Petterson, H. Vrazic, and J. Wilding. "Semaglutide treatment and renal function in the SUSTAIN 6 trial." In Diabetes Kongress 2019 – 54. Jahrestagung der DDG. Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-1688340.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Almatrooshi, Fatima, Sumayya Alhammadi, Said A. Salloum, Iman Akour, and Khaled Shaalan. "A Recommendation System for Diabetes Detection and Treatment." In 2020 International Conference on Communications, Computing, Cybersecurity, and Informatics (CCCI). IEEE, 2020. http://dx.doi.org/10.1109/ccci49893.2020.9256676.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Aliev, M. M. ogly, and E. A. ogly Museibov. "Treatment of urolithiasis in patients with diabetes mellitus." In Scientific dialogue: Medical issues. ЦНК МОАН, 2019. http://dx.doi.org/10.18411/spc-15-05-2019-02.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Río, Nazaret Gómez del, Carina S. González-González, Raquel Martín-González, Vicente Navarro-Adelantado, Pedro Toledo-Delgado, Norberto Marrero-Gordillo, Yeray del Cristo Barrios-Fleitas, Honorio Armas-Ramos, and Francisco Gacía-Peñalvo. "Treatment of children obesity and diabetes through gamification." In TEEM'19: Technological Ecosystems for Enhancing Multiculturality. New York, NY, USA: ACM, 2019. http://dx.doi.org/10.1145/3362789.3362935.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Potančok, Martin, and Martin Antos. "Type 2 Diabetes Diagnosis and Treatment Using mHealth." In 2018 Symposium on Health and Education (SOHE 2018). Paris, France: Atlantis Press, 2018. http://dx.doi.org/10.2991/sohe-18.2018.1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

HASSAN, Neeran F. "USING INCRETIN IN TREATMENT OF DIABETES MELLITUS DISEASE." In IV.International Scientific Congress of Pure,Appliedand Technological Sciences. Rimar Academy, 2022. http://dx.doi.org/10.47832/minarcongress4-29.

Full text
Abstract:
Incretin hormones are gut peptides secreted in response to nutrient ingestion, which play a key role in the regulation of islet function and blood glucose levels. In humans, the major incretin hormones are glucagon-like peptide (GLP)-1 and glucose- dependent insulinotropic polypeptide (GIP), and together they fully account for the incretin effect which is defined as the phenomenon whereby orally ingested glucose elicits a much greater insulin response than that obtained when glucose is infused intravenously to give identical blood glucose levels. there is evidence to suggest that impairments in secretion and/or action of incretin hormones arise secondarily to the development of insulin resistance, glucose intolerance, and/or increases in body weight rather than being causative factors. In separate studies, insulin sensitivity, glucose tolerance, and body mass index (BMI) have all been identified as independent factors associated with reductions in GLP-1 secretion and an impaired incretin effect. In patients with type 2 diabetes, the incretin effect is clearly reduced, which results in an inappropriately low insulin response to the ingestion of nutrients. Several early studies indicated that the reduced incretin effect could, at least in part, be related to impaired secretion of GLP- 1 (whereas secretion of GIP is generally found to be unaltered). Impaired meal-stimulated GLP-1 levels have been reported in some studies of patients with type 2 diabetes.  incretins exert antidiabetic actions in a glucose-dependent manner  Glucagon-like peptide 1 receptor (GLP-1r) agonists, but not dipeptidyl peptidase-4 (DPP-4) inhibitors, inhibit gastric emptying and might cause weight loss  DPP-4 inhibitors can be administered orally and are well tolerated  GLP-1r agonists must be administered by subcutaneous injection and commonly cause nausea. Key words: Incretin, Diabetes Mellitus..
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Diabetes – Treatment"

1

Birkmire-Peters, Deborah, Dale S. Vincent, Joseph Humphry, and Kari-Jo Parisi. Diabetes Care and Treatment. Fort Belvoir, VA: Defense Technical Information Center, September 2007. http://dx.doi.org/10.21236/ada544556.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Yeung, Sai-Ching J. The Impact of Diabetes Treatment on Survival in a Breast Cancer/Diabetes Model. Fort Belvoir, VA: Defense Technical Information Center, October 2008. http://dx.doi.org/10.21236/ada493992.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Bursell, Sven E., and Lloyd M. Aiello. Diabetes Care and Treatment Project: A Joslin Telemedicine Initiative. Fort Belvoir, VA: Defense Technical Information Center, October 2005. http://dx.doi.org/10.21236/ada442772.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Bursell, Sven-Erik. Diabetes Care and Treatment Project: A Joslin Telemedicine Initiative. Fort Belvoir, VA: Defense Technical Information Center, October 2007. http://dx.doi.org/10.21236/ada613095.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Bursell, Sven-Erik. Diabetes Care and Treatment Project: A Joslin Telemedicine Initiative. Fort Belvoir, VA: Defense Technical Information Center, October 2006. http://dx.doi.org/10.21236/ada468625.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Birkmire-Peters, Deborah, Dale S. Vincent, Joseph Humphry, and Kari-Jo Parisi. Diabetes Care and Treatment Program: A Joslin Telemedicine Initiative. Fort Belvoir, VA: Defense Technical Information Center, January 2006. http://dx.doi.org/10.21236/ada544554.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Lau, Namson. Breakthroughs and burdens in a century of diabetes treatment. Edited by Sam Hendricks. Monash University, January 2024. http://dx.doi.org/10.54377/8659-fdc5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Research, Gratis. Brown Fat Activation: A Future Treatment for Obesity & Diabetes. Gratis Research, November 2020. http://dx.doi.org/10.47496/gr.blog.01.

Full text
Abstract:
Brown fat holds a promising therapeutic approach to prevent obesity and type 2 diabetes by its profound effects on body weight reduction, heat generation, increased insulin sensitivity and glucose metabolism regulation
APA, Harvard, Vancouver, ISO, and other styles
9

Bezerra, Alexandre Sacchetti, Flavia Altheman Loureiro, Carla Maria Pasquareli Vazquez, Afonso Cesar Polimanti, and Rafi Felicio Bauab Dauar. Empiric Treatment of Foot Infection in Patients with Severe Diabetes. Science Repository, December 2021. http://dx.doi.org/10.31487/j.jicoa.2021.04.04.

Full text
Abstract:
Background: Despite being treated with antibiotics of broad spectrum recommended by International Consensus, severe diabetic patients with lower limb infection do not present a positive clinical evolution during empirical treatment. This study’s bacterial profile was analysed and compared with other worldwide hospital centers. Objective: To confirm the need of an individualized empirical treatment for severe diabetic patients with foot infection. Methods: Retrospective analysis of cultures and antibiograms of severe diabetic patients admitted by foot infection. Results: The results were consistent with the socioeconomic realities of developing countries. Gram-negative bacteria (52,11%) were present in most bone cultures. Results presented a high incidence of Enterococcus faecalis in both gram-positive (21,2%) and polymicrobial (34,7%) samples. Bacterial resistance with the use of ordinary antibiotics in the statistical analysis was high. Conclusion: The community infections should undergo broad spectrum empirical therapy combining amikacin (80,43%) or meropenem (72,00%) with gram-negative and vancomycin (100%) or teicoplanin (90,00%) or linezolid (74,19%) with gram-positive.
APA, Harvard, Vancouver, ISO, and other styles
10

Vigersky, Robert A. Diabetes Care and Treatment Project: A Diabetes Institute of Walter Reed Health Care System and Joslin Telemedicine Initiative. Fort Belvoir, VA: Defense Technical Information Center, September 2008. http://dx.doi.org/10.21236/ada613912.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Diabetes – Treatment' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography